Healthtech Late Stage Investors & VC Firms
494 firms in this list, with a median first check of $1M. 98 of them lead rounds. Generated from verified public data and updated continuously.
Cambridge Companies
Las VegasSeed–Late Stage
1 person
Ilshin Investment Co. Ltd.
SeoulSeed–Late Stage
1 person
Sk Capital (VEB.RF-backed)
MoscowSeed–Late Stage
1 person
3H Health Investment
ShanghaiSeries A–Late Stage
CICC
BeijingGrowth–Late Stage
Clermont Group
SingaporeGrowth–Late Stage
AFK Sistema
MoscowGrowth–Late Stage
Chow Tai Fook Enterprises
Hong KongGrowth–Late Stage
Everbright Investments
Hong KongGrowth–Late Stage
Imperial Capital Group Ltd
TorontoGrowth–Late Stage
Peloton Capital Management
Toronto, OntarioGrowth–Late Stage
Persistence Capital Partners
MontrealGrowth–Late Stage
WM Partners
Growth–Late Stage
Zero2IPO
BeijingSeries A–Late Stage
Related lists
Healthtech Investors & VC Firms (4190)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)Healthtech Investors & VC Firms in United States (2436)Healthtech Series A Investors & VC Firms (2309)Late Stage Investors & VC Firms (1725)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1357)Healthtech Growth Investors & VC Firms (1269)Healthtech Investors & VC Firms in Global (1181)
Data sourced from public filings and firms' own websites — see our methodology.